Velafermin
Term · Oncology and biomedicine · MLC-T-ONC-009202
A substance that is being studied in the prevention and treatment of oral mucositis (sores in the mouth) in patients receiving high-dose chemotherapy. Velafermin belongs to the family of drugs called recombinant human fibroblast growth factors (rhFGF).
A recombinant human fibroblast growth factor-20 (rhFGF-20) protein with pro-proliferative activity. Velafermin stimulates DNA synthesis and cell proliferation, specifically promoting epithelial and mesenchymal cell proliferation, and may prevent radiation or chemotherapy-induced oral mucositis.
| Identifier | MLC-T-ONC-009202 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rhFGF-20 |
| Synonyms | recombinant human fibroblast growth factor-20; rhFGF-20 |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009202",
"term": "Velafermin",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that is being studied in the prevention and treatment of oral mucositis (sores in the mouth) in patients receiving high-dose chemotherapy. Velafermin belongs to the family of drugs called recombinant human fibroblast growth factors (rhFGF).",
"A recombinant human fibroblast growth factor-20 (rhFGF-20) protein with pro-proliferative activity. Velafermin stimulates DNA synthesis and cell proliferation, specifically promoting epithelial and mesenchymal cell proliferation, and may prevent radiation or chemotherapy-induced oral mucositis."
],
"abbreviation": "rhFGF-20",
"synonyms": [
"recombinant human fibroblast growth factor-20",
"rhFGF-20"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/velafermin/"
}
Record 17,172 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.